Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 190,738 |
|
|||||
| News | - | ||||||
| Day High | 5.61 | Low High |
|||||
| Day Low | 5.24 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Delcath Systems Inc | DCTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.15 | -2.68% | 5.45 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.61 | 5.24 | 5.61 | 5.45 | 5.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,820 | 190,738 | $ 5.43 | $ 1,035,335 | - | 2.25 - 7.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:02 | formt | 100 | $ 5.45 | USD |
Delcath Systems Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 120.15M | 22.05M | - | 2.07M | -47.68M | -2.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Delcath Systems News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DCTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.71 | 5.7415 | 4.26 | 5.10 | 317,729 | 0.74 | 15.71% |
| 1 Month | 4.72 | 5.7415 | 4.26 | 4.99 | 275,811 | 0.73 | 15.47% |
| 3 Months | 4.75 | 5.7415 | 3.70 | 4.62 | 214,855 | 0.70 | 14.74% |
| 6 Months | 3.50 | 5.7415 | 2.25 | 3.77 | 292,121 | 1.95 | 55.71% |
| 1 Year | 6.03 | 7.99 | 2.25 | 5.10 | 739,722 | -0.58 | -9.62% |
| 3 Years | 11.46 | 14.95 | 2.25 | 5.35 | 274,693 | -6.01 | -52.44% |
| 5 Years | 3.77 | 25.18 | 2.25 | 6.51 | 237,822 | 1.68 | 44.56% |
Delcath Systems Description
| Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. |
